This inventor holds 3 USPTO granted patents. Top assignee: Seattle Genetics, Inc.. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Mary Wallace: Innovator in Antibody-Drug Conjugate Formulations
Introduction
Mary Wallace is a prominent inventor based in Bothell, WA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of antibody-drug conjugates. With a total of 3 patents to her name, her work has the potential to impact cancer treatment and drug delivery systems.
Latest Patents
Mary's latest patents focus on cyclodextrin and antibody-drug conjugate formulations. These patents disclose formulations, including both liquid and lyophilized versions, that comprise a benzodiazepine antibody-drug conjugate (ADC) and a cyclodextrin. Additionally, the patents outline methods for purifying mixtures that include benzodiazepine antibody-drug conjugates and process-related drug impurities.
Career Highlights
Mary Wallace is currently employed at Seattle Genetics, Inc., where she continues to innovate in the field of drug formulations. Her expertise in antibody-drug conjugates has positioned her as a key player in the pharmaceutical industry.
Collaborations
Mary has collaborated with notable coworkers, including Hui Li and Shan Jiang, who contribute to her research and development efforts.
Conclusion
Mary Wallace's work in the field of antibody-drug conjugate formulations showcases her innovative spirit and dedication to improving drug delivery systems. Her contributions are paving the way for advancements in cancer treatment and pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile